Work

Bevacizumab and Erlotinib: A Promising New Approach to the Treatment of Advanced NSCLC

Year: 2008

Type: review

Source: The Oncologist

DOI: 10.1634/theoncologist.2008-0108

Authors: Roy S. Herbst, Alan Sandler

Institutions: The University of Texas MD Anderson Cancer Center, Vanderbilt University Medical Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2130431075

FWCI: 1.41

Cites: 82

Cited by: 49

Related to: 10